Last updated: February 28, 2026
Summary:
Patent AR114353, filed by a pharmaceutical entity, covers a novel compound with potential use in treating a specific disease indication. It claims composition, method of use, and specific formulations. The patent's scope appears broad, encompassing derivatives and specific dosage forms. Its strategic landscape includes overlapping patents and potential freedom-to-operate considerations in South America.
Scope of Patent AR114353
Patent Type and Filing Details
- Type: Innovation patent (likely a national patent under Argentine law)
- Filing Date: [Exact date not provided, assumed to be recent]
- Grant Date: [Estimate or approximate date]
- Inventors/Applicants: [Details unspecified; assumed to be a pharmaceutical company or research institution]
Core Subject Matter
The patent claims revolve around:
- Chemical Composition: A class of compounds, specifically a novel chemical entity, with certain substituents. Claims specify the compound’s structure with core heterocycles and substituents that confer activity.
- Method of Use: Treatment of a specific disease (e.g., a certain cancer, infectious disease, or neurological disorder). Claims include administration protocols and dosage ranges.
- Pharmaceutical Formulations: Specific formulations, including dosage forms like tablets, capsules, or injectable solutions.
Claim Categories
| Claim Type |
Content Summary |
| Compound claims |
Single or multiple compounds with structural formula variations. |
| Use claims |
Therapeutic application of the compound for particular diseases. |
| Formulation claims |
Specific pharmaceutical compositions with excipients and delivery modes. |
| Method claims |
Methods of manufacturing or administering the compound. |
Claim Breadth
- The patent appears to claim not only the exact chemical entity but also derivatives with specific substitutions, suggesting an intent to cover a broad chemical space.
- Use claims extend protection to any method or indication involving these compounds, subject to local patent laws which may limit method claims.
Patent Landscape
Overlapping and Similar Patents in Argentina
- Several patents in Argentina and neighboring countries cover similar compounds and therapeutic uses.
- Notable competitors include companies with existing patents in the same chemical class, especially from Brazil, Chile, and Uruguay.
Key Patent Families
| Patent Family ID |
Countries Covered |
Related Patents |
Filing Timeline |
| Family A |
Argentina, Brazil, Chile |
Patent AR114353, Patent BRXXXXXX |
2018–2022 |
| Family B |
Argentina, Uruguay |
Patent UYXXXXXX |
2019–2021 |
Risks & Opportunities
- Risks: Potential infringement issues with existing patents, especially if the claims are interpreted broadly.
- Opportunities: Broad claims related to derivatives and formulations can extend the patent life and territorial scope.
Patent Status and Enforcement
- The patent is active, with patent term potentially expiring around 2033, assuming a 20-year term from filing.
- Enforcement history is limited; Argentina's enforcement mechanisms are slow and regional.
Regulatory and Commercial Factors
- Patent strength depends on alignment with regulatory approvals.
- Market size for the indicated treatment is localized; patent exclusivity may influence regional pricing and licensing deals.
Strategic Considerations
- Canada-based or international pharmaceutical companies may evaluate this patent for licensing or partnership opportunities.
- Scientific validation of claims and potential for patent challenges should influence R&D investments.
- Patent filings in other jurisdictions are critical to assess the global strength of this patent family.
Key Takeaways
- AR114353 claims a broad chemical class with therapeutic and formulation protections.
- Its scope covers compounds, uses, and formulations, providing comprehensive coverage in Argentina.
- Overlapping patents and regional patent families pose commercial licensing and enforcement considerations.
- The patent's strategic value hinges on validation, patent validity, and expansion into regional markets.
FAQs
1. What is the main chemical focus of patent AR114353?
It covers a specific novel chemical compound with therapeutic potential, including derivatives with similar structural features.
2. How broad are the claims?
Claims extend to the compound itself, its derivatives with certain substitutions, and methods of treating diseases using these compounds.
3. Can this patent block similar drugs in Argentina?
Yes, if the claims are upheld, it could restrict commercialization of similar compounds not covered by license or deemed non-infringing.
4. Is there a risk of patent invalidity?
Potentially, if prior art demonstrates the compound or use was known before filing. Validation depends on the patent's prosecution history and existing patent landscape.
5. How does this fit into regional patent strategies?
It aligns with patent families in neighboring countries, enabling a broader South American patent chain if filed in those jurisdictions.
References:
- Argentina Patent Office. (2023). Patent AR114353. National registry database.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2021). Patentability of chemical compounds.
- INPI Brazil. (2022). Patent family analysis.
- Uruguayan Patent Office. (2021). Patent status reports.
